⌘+K

Pulse Explore Communities Researchers Journals

Browser extensionInstagram

Home Communities Explore

May 28, 2018CytotherapyOpen Access

Intrathecal administration of autologous mesenchymal stromal cells for spinal cord injury: Safety and efficacy of the 100/3 guideline

Jesús Vaquero Mercedes Zurita M Rico Concepción Aguayo Celia Bonilla Esperanza Marín Noemí Tapiador Marta González Sevilla David Vázquez Joaquı́n Carballido Cecilia Fernández G. Rodríguez-Boto María Mercedes Ovejero Bruna Jesús Vaquero Mercedes Zurita Celia Bonilla M Rico Concepción Aguayo Alicia Rodríguez Paula Martínez Silvia de la Calle Marta V. Fernández Cecilia Fernández G. Rodríguez-Boto Laura de Reina Anwar Saab Carlos Cotúa Xavier A. Santander Raquel Gutiérrez‐González Cristóbal Saldaña Rasha Mahmoud Hassan C. Ortega Alicia Madrid Montaña Mariscal Esperanza Marín L.F Llopis López Alberto Pérez Edwin E. Ebrat Marta Vaquero Mónica Martín I. Mayoral Dolores Canales Joaquı́n Carballido David Vázquez Rosario Serrano Gertrudis Saucedo Noemí Tapiador Marta González Sevilla Rafael Cabrera Maria E. Martínez Begoña Pérez de Camino Ana Alarcón Tomás Daniel E. Naya Rosalía Alonso Jose R. Alamo Irene Romera Inmaculada Mourelle Sánchez González Rocío Segovia Alberto Gutiérrez Verónica Guillo Sara Y. Del Valle Paula Rey J. Mucientes Rasilla B. Rodríguez Alfonso

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

The present guideline for cell therapy is safe and shows efficacy in patients with SCI, mainly in recovery of sphincter dysfunction, neuropathic pain and sensitivity.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Vaquero et al. (2018) studied this question.

synapsesocial.com/papers/69dc5c274f901957bec103e9 https://doi.org/10.1016/j.jcyt.2018.03.032

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Complete Spinal Cord Injury Treatment Using Autologous Bone Marrow Cell Transplantation and Bone Marrow Stimulation with Granulocyte Macrophage-Colony Stimulating Factor: Phase I/II Clinical TrialCohort Study · 2007 · 384 citations
2A clinical trial report of autologous bone marrow-derived mesenchymal stem cell transplantation in patients with spinal cord injuryHuman Clinical Trial · 2013 · 73 citations
3Safety and neurological assessments after autologous transplantation of bone marrow mesenchymal stem cells in subjects with chronic spinal cord injuryOriginal Research · 2014 · 215 citations
4An approach to personalized cell therapy in chronic complete paraplegia: The Puerta de Hierro phase I/II clinical trialEarly-Phase Clinical Trial · 2016 · 126 citations
5Repeated subarachnoid administrations of autologous mesenchymal stromal cells supported in autologous plasma improve quality of life in patients suffering incomplete spinal cord injuryOriginal Research · 2017 · 136 citations
6World Medical Association Declaration of HelsinkiReview · 2000 · 2,361 citations
7International standards for neurological classification of spinal cord injury (Revised 2011)Original Research · 2011 · 2,327 citations
8Intrathecal Baclofen for Severe Spinal SpasticityRCT · 1989 · 765 citations
9Drug or Medical Technology? China’s Dual-Track Regulation of Cell and Gene Therapy under State Council Order No. 818Cytotherapy · 2026
10Enhanced anti-tumor efficacy through combined CAR T cell therapy and CD40 stimulation in syngeneic solid tumor modelsCytotherapy · 2026

More from Cytotherapy

More from Hospital Universitario Puerta de Hierro Majadahonda